Reaction

Deep Brain Stimulation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 574 reports · 10 co-occurring drugs

As of the last recalculation, Deep Brain Stimulation appears in 574 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CARBIDOPA AND LEVODOPA (PRR 220.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Carbidopa And Levodopa192220.0220.9
Amantadine61159.9160.5
Levodopa45146.4147.0
Rotigotine3799.199.3
Rasagiline Mesylate2171.071.1
Ropinirole2048.949.0
Pramipexole1638.939.0
Pimavanserin Tartrate3927.427.4
Valbenazine45.85.8
Droxidopa35.15.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.